title: Clinical adenoviral gene therapy for prostate cancer.
abstract: Prostate cancer is at present the most common malignancy in men in the Western world. When localized to the prostate, this disease can be treated by curative therapy such as surgery and radiotherapy. However, a substantial number of patients experience a recurrence, resulting in spreading of tumor cells to other parts of the body. In this advanced stage of the disease only palliative treatment is available. Therefore, there is a clear clinical need for new treatment modalities that can, on the one hand, enhance the cure rate of primary therapy for localized prostate cancer and, on the other hand, improve the treatment of metastasized disease. Gene therapy is now being explored in the clinic as a treatment option for the various stages of prostate cancer. Current clinical experiences are based predominantly on trials with adenoviral vectors. As the first of a trilogy of reviews on the state of the art and future prospects of gene therapy in prostate cancer, this review focuses on the clinical experiences and progress of adenovirus-mediated gene therapy for this disease.
authors.affiliation: Department of Urology, Erasmus Medical Center , 3015 GD Rotterdam, The Netherlands.
authors.forename: Ellen
authors.initials: E
authors.lastname: Schenk
authors.forename: Magnus
authors.initials: M
authors.lastname: Essand
authors.forename: Chris H
authors.initials: CH
authors.lastname: Bangma
authors.forename: Chris
authors.initials: C
authors.lastname: Barber
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Behr
authors.forename: Simon
authors.initials: S
authors.lastname: Briggs
authors.forename: Robert
authors.initials: R
authors.lastname: Carlisle
authors.forename: Wing-Shing
authors.initials: WS
authors.lastname: Cheng
authors.forename: Angelika
authors.initials: A
authors.lastname: Danielsson
authors.forename: Iris J C
authors.initials: IJ
authors.lastname: Dautzenberg
authors.forename: Helena
authors.initials: H
authors.lastname: Dzojic
authors.forename: Patrick
authors.initials: P
authors.lastname: Erbacher
authors.forename: Kerry
authors.initials: K
authors.lastname: Fisher
authors.forename: April
authors.initials: A
authors.lastname: Frazier
authors.forename: Lindsay J
authors.initials: LJ
authors.lastname: Georgopoulos
authors.forename: Rob
authors.initials: R
authors.lastname: Hoeben
authors.forename: Stefan
authors.initials: S
authors.lastname: Kochanek
authors.forename: Daniela
authors.initials: D
authors.lastname: Koppers-Lalic
authors.forename: Robert
authors.initials: R
authors.lastname: Kraaij
authors.forename: Florian
authors.initials: F
authors.lastname: Kreppel
authors.forename: Leif
authors.initials: L
authors.lastname: Lindholm
authors.forename: Maria
authors.initials: M
authors.lastname: Magnusson
authors.forename: Norman
authors.initials: N
authors.lastname: Maitland
authors.forename: Patrick
authors.initials: P
authors.lastname: Neuberg
authors.forename: Berith
authors.initials: B
authors.lastname: Nilsson
authors.forename: Manfred
authors.initials: M
authors.lastname: Ogris
authors.forename: Jean-Serge
authors.initials: JS
authors.lastname: Remy
authors.forename: Michelle
authors.initials: M
authors.lastname: Scaife
authors.forename: Erik
authors.initials: E
authors.lastname: Schooten
authors.forename: Len
authors.initials: L
authors.lastname: Seymour
authors.forename: Thomas
authors.initials: T
authors.lastname: Totterman
authors.forename: Taco G
authors.initials: TG
authors.lastname: Uil
authors.forename: Karel
authors.initials: K
authors.lastname: Ulbrich
authors.forename: Joke L M
authors.initials: JL
authors.lastname: Veldhoven-Zweistra
authors.forename: Jeroen
authors.initials: J
authors.lastname: de Vrij
authors.forename: Wytske
authors.initials: W
authors.lastname: van Weerden
authors.forename: Ernst
authors.initials: E
authors.lastname: Wagner
authors.forename: Ralph
authors.initials: R
authors.lastname: Willemsen
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome